STAT+: In private meeting, Trump officials push to onshore generic drugmaking

Trump administration officials, including Marco Rubio, RFK Jr., and Chris Klomp, are rallying industry leaders to boost domestic production of generic drugs. They argue that onshore manufacturing can enhance supply chain resilience and reduce reliance on overseas suppliers, which became especially critical during the pandemic. This push underscores a broader effort to strengthen domestic pharmaceutical capabilities and ensure a more secure and stable drug supply in the future. The initiative could reshape the generic drug market and influence global pharmaceutical strategies.